 A STUDY TO INVESTIGATE THE PHARMACOKINETIC INTERACTIONS BETWEEN SIMEPREVIR AND LEDIPASVIR IN A TREATMENT REGIMEN CONSISTING OF SIMEPREVIR, SOFOSBUVIR, AND LEDIPASVIR IN TREATMENT-NAIVE PARTICIPANTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE 1 INFECTION: 